rs9474143

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_138694.4(PKHD1):​c.234C>T​(p.Asp78Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.259 in 1,612,848 control chromosomes in the GnomAD database, including 56,908 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7247 hom., cov: 32)
Exomes 𝑓: 0.25 ( 49661 hom. )

Consequence

PKHD1
NM_138694.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.45

Publications

20 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-52082439-G-A is Benign according to our data. Variant chr6-52082439-G-A is described in ClinVar as [Benign]. Clinvar id is 96388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.427 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.234C>T p.Asp78Asp synonymous_variant Exon 4 of 67 ENST00000371117.8 NP_619639.3 P08F94-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.234C>T p.Asp78Asp synonymous_variant Exon 4 of 67 1 NM_138694.4 ENSP00000360158.3 P08F94-1
PKHD1ENST00000340994.4 linkc.234C>T p.Asp78Asp synonymous_variant Exon 4 of 61 5 ENSP00000341097.4 P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.300
AC:
45583
AN:
151860
Hom.:
7238
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.391
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.242
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.442
Gnomad SAS
AF:
0.376
Gnomad FIN
AF:
0.323
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.242
Gnomad OTH
AF:
0.279
GnomAD2 exomes
AF:
0.283
AC:
71060
AN:
251366
AF XY:
0.287
show subpopulations
Gnomad AFR exome
AF:
0.387
Gnomad AMR exome
AF:
0.205
Gnomad ASJ exome
AF:
0.258
Gnomad EAS exome
AF:
0.443
Gnomad FIN exome
AF:
0.317
Gnomad NFE exome
AF:
0.240
Gnomad OTH exome
AF:
0.265
GnomAD4 exome
AF:
0.255
AC:
371930
AN:
1460868
Hom.:
49661
Cov.:
35
AF XY:
0.257
AC XY:
186713
AN XY:
726782
show subpopulations
African (AFR)
AF:
0.389
AC:
13023
AN:
33450
American (AMR)
AF:
0.212
AC:
9475
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
6670
AN:
26132
East Asian (EAS)
AF:
0.434
AC:
17245
AN:
39698
South Asian (SAS)
AF:
0.359
AC:
30994
AN:
86230
European-Finnish (FIN)
AF:
0.297
AC:
15853
AN:
53414
Middle Eastern (MID)
AF:
0.294
AC:
1697
AN:
5768
European-Non Finnish (NFE)
AF:
0.235
AC:
260590
AN:
1111074
Other (OTH)
AF:
0.271
AC:
16383
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
14032
28063
42095
56126
70158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9136
18272
27408
36544
45680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.300
AC:
45614
AN:
151980
Hom.:
7247
Cov.:
32
AF XY:
0.305
AC XY:
22686
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.391
AC:
16205
AN:
41436
American (AMR)
AF:
0.242
AC:
3693
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
883
AN:
3468
East Asian (EAS)
AF:
0.442
AC:
2273
AN:
5138
South Asian (SAS)
AF:
0.377
AC:
1814
AN:
4816
European-Finnish (FIN)
AF:
0.323
AC:
3408
AN:
10558
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.242
AC:
16449
AN:
67972
Other (OTH)
AF:
0.279
AC:
588
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1579
3157
4736
6314
7893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.260
Hom.:
11834
Bravo
AF:
0.296
Asia WGS
AF:
0.399
AC:
1383
AN:
3478
EpiCase
AF:
0.245
EpiControl
AF:
0.245

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive polycystic kidney disease Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 11, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The c.234C>T, p.Asp78Asp variant was identified in 27.44% of 34517 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015). -

not provided Benign:1
Sep 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21790888, 25153916) -

Polycystic kidney disease 4 Benign:1
Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.059
DANN
Benign
0.43
PhyloP100
-1.5
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9474143; hg19: chr6-51947237; COSMIC: COSV61861118; API